GlassScriptPhysician profile
Keli Makela Turner
NPI 1700045689
$1,606.55
in general payments reported to CMS, 2019-2025
22 companies · $759 in 2025
The $759 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $90.13 · 2022: $60.21 · 2023: $128 · 2024: $422 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $226.46 | 2021-2025 | Restrata Wound Matrix |
| Solventum Corporation | $155.22 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Ethicon US, LLC | $141.66 | 2024 | Echelon Circular |
| Alexion Pharmaceuticals, INC. | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.36 | 2024-2025 | Gattex |
| Dilon Technologies, INC. | $110.59 | 2025 | Hemoblast Bellows |
| Glaxosmithkline, LLC. | $101.10 | 2025 | |
| Medtronic, INC. | $98.23 | 2023-2025 | Signia, Interstim, Ligasure |
| Novo Nordisk INC | $82.79 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $63.07 | 2024-2025 | Exparel |
| Iovance Biotherapeutics, INC. | $61.37 | 2025 | Amtagvi |
| Kerecis Limited | $59.63 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Convatec INC. | $54.25 | 2023-2025 | |
| Mimedx Group, INC. | $39.01 | 2024 | |
| Nestle Healthcare Nutrition INC. | $31.10 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29.63 | 2025 | Grafix Pl, Grafix Xc |
| Tela Bio, INC. | $23.07 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $21.34 | 2019 | |
| Reprise Biomedical, INC. | $20.23 | 2025 | Miro 3d |
| Hologic Sales and Service, LLC | $19.65 | 2025 | Aptima |
| Kci USA, INC. | $18.34 | 2021 | |
| Edwards Lifesciences Corporation | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keli Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.